Sarcoid arthritis in children
…, WM Gibson, JE Levinson, SL Schuchter… - The American journal of …, 1970 - Elsevier
The clinical features of the six cases of sarcoid arthritis here reported, and of the five previously
recorded cases of sarcoid arthritis in childhood, appear to form a syndrome characterized …
recorded cases of sarcoid arthritis in childhood, appear to form a syndrome characterized …
[CITATION][C] Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis
AL SCHERBEL, SL SCHUCHTER… - Cleveland Clinic …, 1957 - pubmed.ncbi.nlm.nih.gov
… AL SCHERBEL, SL SCHUCHTER, JW HARRISON …
[CITATION][C] Intraarticular administration of nitrogen mustard alone and combined with a corticosteroid for rheumatoid arthritis; experimental and clinical studies
AL SCHERBEL, SL SCHUCHTER… - Cleveland Clinic …, 1957 - pubmed.ncbi.nlm.nih.gov
… AL SCHERBEL, SL SCHUCHTER, SJ WEYMAN …
The state of melanoma: challenges and opportunities
…, G McArthur, A Ribas, L Schuchter… - Pigment cell & …, 2016 - Wiley Online Library
The Melanoma Research Foundation ( MRF ) has charted a comprehensive assessment of
the current state of melanoma research and care. Intensive discussions among members of …
the current state of melanoma research and care. Intensive discussions among members of …
Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma
…, M Herlyn, R Amaravadi, LM Schuchter… - EMBO molecular …, 2018 - embopress.org
Despite novel therapies for melanoma, drug resistance remains a significant hurdle to achieving
optimal responses. NRAS ‐mutant melanoma is an archetype of therapeutic challenges …
optimal responses. NRAS ‐mutant melanoma is an archetype of therapeutic challenges …
Adjuvant nivolumab in high-risk stage IIb/IIc melanoma patients: Results from investigator initiated clinical trial.
…, C Chiuzan, B Leiby, K Senter, LM Schuchter… - 2021 - ascopubs.org
9583 Background: Recent studies have shown 5-yr recurrence rates for Stage IIB and IIC
melanoma of up to 46%. These high-risk patients currently have few options for adjuvant …
melanoma of up to 46%. These high-risk patients currently have few options for adjuvant …
Comparison of BRAF inhibitor (BRAFi)-induced cutaneous squamous cell carcinoma (cuSCC) and secondary malignancies in BRAF mutation-positive metastatic …
9016 Background: The MAP kinase (MAPK) pathway is of critical importance for keratinocyte
proliferation and maturation and is essential for epidermal homeostasis. Occurrence of …
proliferation and maturation and is essential for epidermal homeostasis. Occurrence of …
NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib
…, DE Elder, R Amaravadi, LM Schuchter… - Journal of cutaneous …, 2019 - Wiley Online Library
Background BRAF inhibition has improved overall survival in patients with BRAF mutant
melanoma, but this is associated with a range of known and predictable cutaneous side effects, …
melanoma, but this is associated with a range of known and predictable cutaneous side effects, …
Final Results of a Phase I “RadVax” Trial of Hypofractionated Radiation Combined With Pembrolizumab in Patients With Metastatic Solid Tumors
…, TC Mitchell, R Amaravadi, LM Schuchter… - International Journal of …, 2021 - redjournal.org
Purpose/Objective(s) Many patients treated with anti-PD-1 therapy do not show a clinical
response. Preclinical studies suggest that adding hypofractionated radiotherapy (HFRT) to anti-…
response. Preclinical studies suggest that adding hypofractionated radiotherapy (HFRT) to anti-…
Dr. Zisook and Dr. Schuchter Reply
S ZISOOK, SR SCHUCHTER - American Journal of …, 1992 - Am Psychiatric Assoc
580 Am J Psychiatry 1 49: 4, April 1992 in the study of the consequences of bereavement. I
do think that study of treatment for a subtypology such as the combination of bereavement …
do think that study of treatment for a subtypology such as the combination of bereavement …